Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
09 5월 2008 - 4:00AM
PR Newswire (US)
Presentation Will be Webcast Live and Archived on Company's Website
ROCKVILLE, Md., May 8 /PRNewswire-FirstCall/ -- Vanda
Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company
focused on the development and commercialization of clinical-stage
product candidates for central nervous system disorders, today
announced that the company will deliver a corporate presentation on
Tuesday, May 13, 2008, at 5:20 p.m. Pacific Time. The presentation
will take place as part of the 2008 Bank of America Healthcare
Conference at the Four Seasons, Las Vegas, Nevada. The presentation
will be available live on the Vanda Website, where it also will be
archived for 30 days. To access the presentation, log on to
http://www.vandapharma.com/ and click on the Presentations option
in the Investor Relations section. Please connect to the website
several minutes prior to the start of the live presentation About
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
is a biopharmaceutical company focused on the development and
commercialization of clinical-stage product candidates for central
nervous system disorders. The company has three product candidates.
Vanda's lead product candidate, Fanapta(TM) (iloperidone), for
which Vanda has recently submitted an NDA to the FDA, is a compound
for the treatment of schizophrenia. Vanda's second product
candidate, tasimelteon (VEC-162), is a compound for the treatment
of sleep and mood disorders, which is currently in Phase III for
chronic primary insomnia. Vanda's third product candidate, VSF-173,
is a compound for the treatment of excessive sleepiness in Phase
II. For more on Vanda Pharmaceuticals Inc., please visit
http://www.vandapharma.com/. DATASOURCE: Vanda Pharmaceuticals Inc.
CONTACT: Steven Shallcross, Chief Financial Officer of Vanda
Pharmaceuticals Inc., +1-240-599-4500, Web site:
http://www.vandapharma.com/
Copyright
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024